Armistice Capital’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$14.3M Sell
1,284,720
-239,897
-16% -$3.05M 0.25% 73
2025
Q4
$25M Buy
1,524,617
+180,333
+13% +$2.81M 0.3% 55
2025
Q3
$18M Buy
1,344,284
+652,284
+94% +$7.71M 0.27% 60
2025
Q2
$8.86M Sell
692,000
-1,107,689
-62% -$13.3M 0.15% 74
2025
Q1
$18.5M Buy
1,799,689
+1,237,782
+220% +$15.9M 0.28% 68
2024
Q4
$7.14M Buy
561,907
+71,292
+15% +$942K 0.1% 112
2024
Q3
$6.28M Sell
490,615
-235,905
-32% -$2.89M 0.1% 111
2024
Q2
$9.21M Buy
726,520
+353,781
+95% +$6.12M 0.12% 94
2024
Q1
$8.45M Buy
372,739
+136,739
+58% +$3.2M 0.11% 105
2023
Q4
$5.86M Sell
236,000
-336,189
-59% -$6.56M 0.08% 116
2023
Q3
$9.79M Sell
572,189
-91,811
-14% -$1.53M 0.15% 90
2023
Q2
$11M Buy
+664,000
New +$10.6M 0.16% 87

Other funds holding PATH

Armistice Capital's PATH Position: Q1 2026 in Review

Armistice Capital reduced its UiPath (PATH) stake by 16% in Q1 2026, selling an estimated $3.05M and leaving 1,284,720 shares worth $14.3M. The position accounts for 0.25% of the portfolio, ranked #73.

Armistice Capital first reported a position in PATH in Q2 2023 and has held it in 12 quarters since. The position peaked at $25M in Q4 2025. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Armistice Capital held 1,284,720 shares of UiPath worth $14.3M as of Q1 2026.
  • Armistice Capital sold 239,897 UiPath shares in Q1 2026, an estimated $3.05M.
  • UiPath made up 0.25% of Armistice Capital's portfolio in Q1 2026, its #73 holding.
  • Armistice Capital first reported a position in UiPath in Q2 2023 and has held it in 12 quarters since.
  • Armistice Capital's UiPath position peaked at $25M in Q4 2025.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Armistice Capital's 13F filing for Q1 2026, filed 15 May 2026.